Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.

Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.

BACKGROUND:Many prevention of mother-to-child HIV transmission (PMTCT) programs currently prioritize antiretroviral therapy (ART) for women with advanced HIV. Point-of-care (POC) CD4 assays may expedite the selection of three-drug ART instead of zidovudine, but are costlier than traditional laborato...

Full description

Bibliographic Details
Main Authors:	Andrea L Ciaranello, Landon Myer, Kathleen Kelly, Sarah Christensen, Kristen Daskilewicz, Katie Doherty, Linda-Gail Bekker, Taige Hou, Robin Wood, Jordan A Francke, Kara Wools-Kaloustian, Kenneth A Freedberg, Rochelle P Walensky
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4355621?pdf=render

Similar Items

Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa.
by: Caitlin M Dugdale, et al.
Published: (2019-01-01)

Integration of antiretroviral therapy services into antenatal care increases treatment initiation during pregnancy: a cohort study.
by: Kathryn Stinson, et al.
Published: (2013-01-01)

Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study
by: Myer Landon, et al.
Published: (2012-09-01)

Is self-assessment of medical abortion using a low-sensitivity pregnancy test combined with a checklist and phone text messages feasible in South African primary healthcare settings? A randomized trial.
by: Deborah Constant, et al.
Published: (2017-01-01)

Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
by: Freedberg Kenneth A, et al.
Published: (2011-05-01)

Sub optimal HIV status ascertainment at antenatal clinics and the impact on HIV prevalence estimates: A cross sectional study
by: Fatihiyya Wangara, et al.
Published: (2022-01-01)

Sub optimal HIV status ascertainment at antenatal clinics and the impact on HIV prevalence estimates: A cross sectional study.
by: Fatihiyya Wangara, et al.
Published: (2022-01-01)

Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa.
by: Darshini Govindasamy, et al.
Published: (2013-01-01)

National antiretroviral treatment register - a necessity?
by: Robin Wood, et al.
Published: (2003-07-01)

Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis.
by: Rochelle P Walensky, et al.
Published: (2010-12-01)

Contraception use and HIV outcomes among women initiating dolutegravir‐containing antiretroviral therapy in Kenya: a retrospective cohort study
by: John M. Humphrey, et al.
Published: (2022-12-01)

Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa.
by: Rachel C Vreeman, et al.
Published: (2018-01-01)

Delivery of antiretroviral therapy to HIV-infected women during the postpartum period: The Postpartum Adherence Clubs for Antiretroviral Therapy (PACART) trial
by: Jasantha Odayar, et al.
Published: (2019-12-01)

Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.
by: Abraham M Siika, et al.
Published: (2013-01-01)

Linkage of HIV-infected infants from diagnosis to antiretroviral therapy services across the Western Cape, South Africa.
by: Nei-Yuan Hsiao, et al.
Published: (2013-01-01)

Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa
by: Bangani Nonzwakazi, et al.
Published: (2007-05-01)

Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study
by: Sebastian Elaine, et al.
Published: (2011-06-01)

Preferences for Multipurpose Technology and Non-oral Methods of Antiretroviral Therapy Among Women Living With HIV in Western Kenya: A Survey Study
by: Caitlin Bernard, et al.
Published: (2022-05-01)

Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers
by: Djøra I. Soeteman, et al.
Published: (2020-06-01)

Partnerships, Collaborations, and Investments Integral to CDC’s International Response to COVID-19
by: Rochelle P. Walensky
Published: (2022-11-01)

WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
by: Andrea L Ciaranello, et al.
Published: (2011-01-01)

What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.
by: Andrea L Ciaranello, et al.
Published: (2012-01-01)

Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
by: Ankur Gupta, et al.
Published: (2013-01-01)

Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis.
by: Eric N Ouattara, et al.
Published: (2019-01-01)

Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness.
by: Ingrid V Bassett, et al.
Published: (2014-01-01)

Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
by: Ankur Gupta, et al.
Published: (2012-01-01)

Cost-effectiveness of highly active antiretroviral therapy in South Africa.
by: Motasim Badri, et al.
Published: (2006-01-01)

Rates of switching antiretroviral drugs in a primary care service in South Africa before and after introduction of tenofovir.
by: Christine Njuguna, et al.
Published: (2013-01-01)

Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa.
by: Katharina Kranzer, et al.
Published: (2010-11-01)

Identification of losses to follow-up in a community-based antiretroviral therapy clinic in South Africa using a computerized pharmacy tracking system
by: Bekker Linda-Gail, et al.
Published: (2010-11-01)

Physical development and mental health in South African perinatally HIV-positive adolescents on antiretroviral therapy and their caregivers with and without household food insecurity
by: Sarah Heany, et al.
Published: (2021-12-01)

Stated-preference research in HIV: A scoping review.
by: John M Humphrey, et al.
Published: (2019-01-01)

Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis.
by: Helen van der Plas, et al.
Published: (2013-01-01)

Prospective evaluation of the impact of potent antiretroviral therapy on the incidence of Kaposi’s Sarcoma in East Africa: findings from the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Consortium
by: Martin Jeffrey, et al.
Published: (2012-04-01)

From the Editor
by: Landon Myer
Published: (2014-01-01)

From the Editor
by: Landon Myer
Published: (2012-06-01)

Message from the Editor
by: Landon Myer
Published: (2013-09-01)

CPD Questionnaire
by: Landon Myer
Published: (2014-09-01)

Message from the Editor
by: Landon Myer
Published: (2014-05-01)

From the Editor
by: Landon Myer
Published: (2012-03-01)